Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vaccines Lab is a Malaysia-based vaccine-focused company operating as Vaccines Lab Sdn Bhd. Publicly available information indicates that it focuses on human vaccine clinical trials, regulatory registration, sourcing, distribution, and commercialization in Southeast Asia, rather than developing a broad proprietary therapeutic pipeline. The company has been described as a subsidiary within the Nexgram/NMed Bioscience group and has been linked to a strategic joint venture with Rafarma Pharmaceuticals to support vaccine research, clinical development, licensing, and regional commercialization. Available sources suggest its business model centers on regional market access and commercialization of vaccine products in ASEAN markets. There is limited evidence in public sources of a disclosed independent multi-asset clinical pipeline or named in-house vaccine candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vaccines Lab.